Resumen de acción AMRUTANJAN
Amrutanjan Health Care Limited fabrica, suministra y vende bálsamos ayurvédicos para el dolor y productos de higiene femenina.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Recompensas
Análisis de riesgos
Competidores de Amrutanjan Health Care Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹775.75 |
| 52 Week High | ₹804.00 |
| 52 Week Low | ₹563.90 |
| Beta | 0.71 |
| 1 Month Change | 18.94% |
| 3 Month Change | 35.23% |
| 1 Year Change | 29.25% |
| 3 Year Change | 23.26% |
| 5 Year Change | 171.05% |
| Change since IPO | 1,578.75% |
Noticias y actualizaciones recientes
Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Recent updates
Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29Rentabilidad de los accionistas
| AMRUTANJAN | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 13.8% | 0.8% | 0.5% |
| 1Y | 29.2% | 58.6% | 44.7% |
Rentabilidad vs. Industria: AMRUTANJAN obtuvo unos resultados inferiores a los del sector Indian Pharmaceuticals , que el año pasado arrojó un rendimiento del 56.7%.
Rentabilidad vs. Mercado: AMRUTANJAN obtuvo unos resultados inferiores a los del mercado Indian, que fue del 45% el año pasado.
Volatilidad de los precios
| AMRUTANJAN volatility | |
|---|---|
| AMRUTANJAN Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: El precio de las acciones de AMRUTANJAN ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de AMRUTANJAN (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1893 | 537 | Sambhu Sivalenka | www.amrutanjan.com |
Amrutanjan Health Care Limited fabrica, suministra y vende bálsamos ayurvédicos para el dolor y productos de higiene femenina. La empresa opera a través de los segmentos de Productos OTC, Bebidas y Otros. Ofrece productos para el tratamiento del dolor que comprenden bálsamos y roll-ons para el dolor; y roll-ons para el dolor de espalda, parches adhesivos, geles para el dolor corporal y sprays musculares para las articulaciones.
Resumen de fundamentos de Amrutanjan Health Care Limited
| Estadísticas fundamentales de AMRUTANJAN | |
|---|---|
| Capitalización bursátil | ₹22.42b |
| Beneficios(TTM) | ₹440.09m |
| Ingresos (TTM) | ₹3.95b |
50.9x
Ratio precio-beneficio (PE)5.7x
Ratio precio-ventas (PS)¿Está AMRUTANJAN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de AMRUTANJAN | |
|---|---|
| Ingresos | ₹3.95b |
| Coste de los ingresos | ₹2.05b |
| Beneficio bruto | ₹1.90b |
| Otros gastos | ₹1.46b |
| Beneficios | ₹440.09m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 15.22 |
| Margen bruto | 48.15% |
| Margen de beneficio neto | 11.15% |
| Ratio deuda/patrimonio | 0.3% |
¿Cómo se ha desempeñado AMRUTANJAN a largo plazo?
Ver rendimiento histórico y comparativa